{"name":"Amphastar Pharmaceuticals, Inc.","slug":"amphastar-pharmaceuticals-inc","ticker":"","exchange":"","domain":"amphastar.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"immunology","drugs":[{"name":"Arm T1: Primatene Mist HFA","genericName":"Arm T1: Primatene Mist HFA","slug":"arm-t1-primatene-mist-hfa","indication":"Relief of acute asthma symptoms","status":"phase_2"},{"name":"Primatene Mist","genericName":"Primatene Mist","slug":"primatene-mist","indication":"Acute bronchospasm and asthma attacks (over-the-counter emergency relief)","status":"marketed"},{"name":"Epinephrine HFA-MDI (E004)","genericName":"Epinephrine HFA-MDI (E004)","slug":"epinephrine-hfa-mdi-e004","indication":"Acute asthma exacerbation","status":"phase_3"},{"name":"albuterol inhalation aerosol","genericName":"albuterol inhalation aerosol","slug":"albuterol-inhalation-aerosol","indication":"Maintenance and relief of bronchospasm in patients with asthma and in patients with COPD","status":"phase_3"},{"name":"albuterol inhalation powder","genericName":"albuterol inhalation powder","slug":"albuterol-inhalation-powder","indication":"Acute bronchospasm relief in asthma","status":"phase_3"},{"name":"epinephrine inhalation aerosol","genericName":"epinephrine inhalation aerosol","slug":"epinephrine-inhalation-aerosol","indication":"Relief of acute bronchospasm in asthma and other obstructive airway diseases","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Epinephrine inhalation","genericName":"Epinephrine inhalation","slug":"epinephrine-inhalation","indication":"Acute bronchospasm and croup in pediatric patients","status":"marketed"},{"name":"Arm T2: Primatene Mist HFA","genericName":"Arm T2: Primatene Mist HFA","slug":"arm-t2-primatene-mist-hfa","indication":"Other","status":"phase_2"},{"name":"A006 DPI","genericName":"A006 DPI","slug":"a006-dpi","indication":"Other","status":"phase_2"},{"name":"Placebo DPI","genericName":"Placebo DPI","slug":"placebo-dpi","indication":"Clinical trial control / comparator product","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"A006","genericName":"A006","slug":"a006","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Epinephrine inhalation","genericName":"Epinephrine inhalation","slug":"epinephrine-inhalation","phase":"marketed","mechanism":"Epinephrine inhalation is a bronchodilator that stimulates alpha and beta-adrenergic receptors to rapidly relieve acute bronchospasm and airway obstruction.","indications":["Acute bronchospasm and croup in pediatric patients","Emergency relief of acute airway obstruction"],"catalyst":""},{"name":"Arm T1: Primatene Mist HFA","genericName":"Arm T1: Primatene Mist HFA","slug":"arm-t1-primatene-mist-hfa","phase":"phase_2","mechanism":"Primatene Mist HFA is a bronchodilator that contains epinephrine, which works by relaxing the muscles in the airways and increasing air flow to the lungs.","indications":["Relief of acute asthma symptoms","Relief of acute bronchospasm in COPD"],"catalyst":""},{"name":"Arm T2: Primatene Mist HFA","genericName":"Arm T2: Primatene Mist HFA","slug":"arm-t2-primatene-mist-hfa","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Primatene Mist","genericName":"Primatene Mist","slug":"primatene-mist","phase":"marketed","mechanism":"Epinephrine acts as a beta-2 adrenergic agonist to relax bronchial smooth muscle and relieve acute bronchospasm.","indications":["Acute bronchospasm and asthma attacks (over-the-counter emergency relief)"],"catalyst":""},{"name":"A006","genericName":"A006","slug":"a006","phase":"phase_2","mechanism":"A006 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""},{"name":"A006 DPI","genericName":"A006 DPI","slug":"a006-dpi","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Epinephrine HFA-MDI (E004)","genericName":"Epinephrine HFA-MDI (E004)","slug":"epinephrine-hfa-mdi-e004","phase":"phase_3","mechanism":"Epinephrine is a sympathomimetic amine that binds to alpha and beta adrenergic receptors to produce rapid bronchodilation, increased heart rate, and vasoconstriction.","indications":["Acute asthma exacerbation","Anaphylaxis"],"catalyst":""},{"name":"Placebo DPI","genericName":"Placebo DPI","slug":"placebo-dpi","phase":"marketed","mechanism":"Placebo DPI is an inert formulation delivered via dry powder inhaler that produces no pharmacological effect.","indications":["Clinical trial control / comparator product"],"catalyst":""},{"name":"albuterol inhalation aerosol","genericName":"albuterol inhalation aerosol","slug":"albuterol-inhalation-aerosol","phase":"phase_3","mechanism":"Albuterol inhalation aerosol is a beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.","indications":["Maintenance and relief of bronchospasm in patients with asthma and in patients with COPD"],"catalyst":""},{"name":"albuterol inhalation powder","genericName":"albuterol inhalation powder","slug":"albuterol-inhalation-powder","phase":"phase_3","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Acute bronchospasm relief in asthma","Chronic obstructive pulmonary disease (COPD) maintenance and acute symptom relief"],"catalyst":""},{"name":"epinephrine inhalation aerosol","genericName":"epinephrine inhalation aerosol","slug":"epinephrine-inhalation-aerosol","phase":"phase_3","mechanism":"Epinephrine inhalation aerosol works by stimulating the beta-2 adrenergic receptors in the lungs to cause bronchodilation.","indications":["Relief of acute bronchospasm in asthma and other obstructive airway diseases"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9yRUxBZ0h2QUh2VWZFQzV3UlZMSlBQQndKTi1DbUV0UlpHdEh5R1lqc1BleEJpRnJfeHp2cXhmWHJMU1UwMDNnQTVpM0phLWM5NzVV?oc=5","date":"2026-04-04","type":"pipeline","source":"Benzinga Japan","summary":"Amphastar Pharma (AMPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan","headline":"Amphastar Pharma (AMPH) Stock Analysis Report | Ratings, Financials & Performance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOQ1Y1RUxQZUw0eDFUSFFXdG9FU0Y5ME8taDg5QTk0YklnN0lLYkctVFB1dUstZzdfeUpBNjQ3N0FPTzA0UTVtOUpzODBOSHE4VERGRlRPSTFvVFJ3N3BWRXUwdjg0R3VKYTBNcU1maENKRTRoVU9wR01Ca05teDgzbDNnX1o3WndZNG1nNm9OcmZsY29k?oc=5","date":"2026-03-05","type":"earnings","source":"Yahoo Finance","summary":"Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) - Yahoo Finance","headline":"Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMTVUMGdmbDhvZ0ZtRUVTZUkybmRENlBfalFkRlVDc2djZ3FmNDQzY0F1Z1d5WlVvU083aEt0VlFWYVdwZ19UVklFcnpxRy04TS1VY1VxaDVfaTl1ZTBPckN5Vkc1T3NwYzdKN1ctU3dUbS1JcjU3LUMwMTY5WlRyTzR3MFVpOEEzLU1XNllwaENEay1VRjcyczRlbXJwaXFlLVV5cDNkVUhiQTJPX3MyVGw4OUVreU9Eck1N?oc=5","date":"2026-02-26","type":"earnings","source":"Finviz","summary":"Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% - Finviz","headline":"Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7%","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObVRFek5Na3FGQlB4WEVvd0RBZ0NfYzhfdF8yVmJBVlFRN01EaEZZbldiMzJjYVp3TmJXb1FJTkZLck1NM0VsOGFrRl9CQzFCaWtwRjIwQU5CcmVEN0F3WUQwV21CdmRKUjFISzBRdkRlckN6Y0xqb0dVLTN5X3FGRmwxN18taGdubGIydVNJZ1RqVUJaQVNCVklqS1YxcEtyWktIdG1vTWZ5cm9pTUxmeW1Zci1WbGkyTFB2eTVUQjZWY0tOQzRYQ0dfUmhyZkxOUmZpUkZSVzg?oc=5","date":"2026-02-24","type":"regulatory","source":"ACCESS Newswire","summary":"Amphastar Announces FDA Approval for Ipratropium Bromide HFA - ACCESS Newswire","headline":"Amphastar Announces FDA Approval for Ipratropium Bromide HFA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQcmQ0UnU1RmNYN2tGRlRvSFhLcFZCMVJURW84MjBYa2VSNHRKLXFMV2d5My1mMUEtRUFuV0NOdkIwTE5zblJsd2ZKaHBrcTlTaGc5OTMxRjU3QmlsMFBfeUpmd1dmYUhkeFdFdU03UUI4cTNicmRGcEZpQm5oNHlqc01OMmdjOUFqamhYWVpFRExmaXI1T2xzaGlCaG1tY2JFWm5oVXowaU04TER6?oc=5","date":"2026-01-12","type":"deal","source":"Contract Pharma","summary":"Amphastar, Hanxin Enter Exclusive License Agreement for AMP-110 - Contract Pharma","headline":"Amphastar, Hanxin Enter Exclusive License Agreement for AMP-110","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQSUF5NU5xSVFBXzAwSVM1MmJDekdLQkYtODJpNVF5ODhNQnhnWWthV05FeEc3TFdod0pFVnBPeFRmdzBhblY2aW1XbzVIOVl5Nmx2b1d1a0VDMEwyMVZWa0daZFhpNUhtV2NmclNGT283M3ZtdGgxWXZrNHhHTXJUd1I4QlJ6NFNLMGdGNEVCRTltTW9kRjBKeUVKY3VwTldTQ2N3ZUh0RnNrZzJjNURZTHNLc1A1TnVuRHB1c0l0eVZVdW5wcmN6VmxIbnJhQ3pkVEY5SUtJM0s4dHl0dEMwS2RvNA?oc=5","date":"2026-01-12","type":"deal","source":"ACCESS Newswire","summary":"Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - ACCESS Newswire","headline":"Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPU2tOQTJ3ZkRCVldHSUNNRVZua3RrRE5VSExlR29rOFQ2cTRFamtIY2RtUHM4VWFLaDZiQ2VHN29KY0doYTIzRFpJQllxMVVqTmVQZmJ4ZHpsTkwzeGl0REdIRVBmUWtWbDRuQlAxRlRva2hqVHNmZTdZSUQyN2ZzRzhad3JnbmRwWk8zNDNfaw?oc=5","date":"2026-01-12","type":"pipeline","source":"Yahoo Finance","summary":"Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today - Yahoo Finance","headline":"Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPMHJWUDVRV3Z0RUNxQVdKbVNIZTJUR2o0OXp4UkN5OWNham1nZFRjN3FxZVhEWkRjMUhPX1JqT2d6RXNoQUI3bXZFbnd3Vmg3YmxqdXJwUGR0OGJmZ19uQnR5UEdUeW1aM2xvS0JFbjhjUkhBT1dqVGQwMmxaYlNPODlzZTNrU25USE43aTNNZkVLb2FxSGVSNnZMd19Gd05VRVE?oc=5","date":"2025-09-23","type":"pipeline","source":"Seeking Alpha","summary":"After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH) - Seeking Alpha","headline":"After Protracted Sell-Off, Amphastar Looks Like A Value Pick (NASDAQ:AMPH)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNMDg2LURaOGdDRUZicnVKVmkzWmZyN0o3aVc1QzBtczF6X3R6T3phSzJEVmg3Yk1yVjZrVlBjY3JydWQ2S2QtREVvNnh0R3o0VXJvY21ZQmpYejhITHdldHZUNThfQUVyTDNtaUxNVmw5NHVkdTk2WHZrOGJ5TTFmMlNZYWJMLXIxR3B3cmFhYkZJb0JobkFwNERDeE1wNzd3aTRPOWJNRkdQWTBzT2lkcGxuUlN6bVVUMWpQZFpFQkRjY1Ut?oc=5","date":"2025-08-13","type":"regulatory","source":"Fierce Pharma","summary":"CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar - Fierce Pharma","headline":"CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOZGVYNEJxSllWOVBUeE9SREtvZFVRUi1qU0tDSnhFalJySjhzdWJXUkdrRXlrNDBsdUFLbF9KM2NfOW1YUGUtdnFhWkJXN0xKU05XbVdmRTBiTjMyS0Y2YTByZkZZV1IwNXpPcmNoeWxuX2NvNko5Z0d1NVJPdFBveXI3clBLMTc0N2FLRl9Lc2VKbU9hLVlMemx0M3Ixbk16VVI3VHlia0FDSmEyYzVudWtSSnVtajlWV1VUcmNNSVV2VlNNN281dkhkSTFmbjh0dVI4eldiYmF2dXNXUEd0Vg?oc=5","date":"2025-07-18","type":"pipeline","source":"Pharmaceutical Online","summary":"Amphastar Pharmaceuticals Announces Multi-Year Expansion Of US Manufacturing Operations In California - Pharmaceutical Online","headline":"Amphastar Pharmaceuticals Announces Multi-Year Expansion Of US Manufacturing Operations In California","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNa0VIamZ5MnUyYWRxUUdqOG5IUUd2RjA5Mk8yU0hubE9vZi1jOFJvNWp5cXNVb1hFRUhyNlVJYlpOc3Z1bXNDdkpDOVAzeWJlMEtoZmVXb3ZfelkzU3dob1kyR3FTYW9tNkdodGJNeWZ3bHB0OEFaYVRmUWNNU3BBc1Y0bVVXSVdqcGVhX0VJZ0I4WVZzeWhYTDAtRGJ1RTQ?oc=5","date":"2025-07-15","type":"pipeline","source":"Association for Accessible Medicines","summary":"Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines","headline":"Amphastar to Quadruple Domestic Manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1VNHVrcUtkeU9sV0RNOVU2VVZibXhqUy14cUo1QVJPVXpEXzc3NGlvNWF4NlN4ZnoyQ0h4YXAtY1pYZjFNS0tTM0hZQ3BfZngweUlv?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"AMPH Stock Price, News & Analysis - Stock Titan","headline":"AMPH Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":11,"phaseCounts":{"marketed":3,"phase_2":4,"phase_3":4},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}